Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Nature Biotechnology|March 11, 2021
Life sciences intellectual property licensing at the Massachusetts Institute of TechnologySamuel Huang, Kien Wei Siah, Detelina Vasileva, et al.
The Milbank Quarterly|January 18, 2025
Innovative Insurance to Improve US Patient Access to Cell and Gene TherapyRena M Conti, Patrick Demartino, Jonathan Gruber, et al.
ACS Chemical Biology|April 26, 2013
Lipid nanoparticles improve activity of single-stranded siRNA and gapmer antisense oligonucleotides in animalsThazha P Prakash, Walt F Lima, Heather M Murray, et al.
Plos One|July 25, 2022
Real-time extended psychophysiological analysis of financial risk processingManish Singh, Qingyang Xu, Sarah J Wang, et al.
Gene Therapy|November 7, 2023
The estimated annual financial impact of gene therapy in the United StatesChi Heem Wong, Dexin Li, Nina Wang, et al.
Drug Discovery Today|November 26, 2013
Financing drug discovery for orphan diseasesDavid E Fagnan, Austin A Gromatzky, Roger M Stein, et al.
Drug Discovery Today|March 30, 2021
Accelerating glioblastoma therapeutics via venture philanthropyKien Wei Siah, Qingyang Xu, Kirk Tanner, et al.
Nucleic Acid Therapeutics|February 2, 2017
The Effects of 2'-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical TrialsStanley T Crooke, Brenda F Baker, Joseph L Witztum, et al.
Nucleic Acids Research|March 11, 2015
Identification of metabolically stable 5'-phosphate analogs that support single-stranded siRNA activityThazha P Prakash, Walt F Lima, Heather M Murray, et al.
Nucleic Acids Research|September 22, 2017
Antisense oligonucleotides targeting translation inhibitory elements in 5' UTRs can selectively increase protein levelsXue-Hai Liang, Hong Sun, Wen Shen, et al.
Pageof 17